These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33822210)

  • 1. The Addictive Potential and Challenges with Use of the "Herbal Supplement" Kratom: A Case Report and Literature Review.
    Anand A; Hosanagar A
    Pain Med; 2022 Jan; 23(1):4-9. PubMed ID: 33822210
    [No Abstract]   [Full Text] [Related]  

  • 2. Kratom: Implications for Health Care Providers.
    Goldin D; Salani D; Mckay M
    J Psychosoc Nurs Ment Health Serv; 2019 Dec; 57(12):15-20. PubMed ID: 31774129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance.
    Buresh M
    J Addict Med; 2018; 12(6):481-483. PubMed ID: 29944481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legally Lethal Kratom: A Herbal Supplement with Overdose Potential.
    Palasamudram Shekar S; Rojas EE; D'Angelo CC; Gillenwater SR; Martinez Galvis NP
    J Psychoactive Drugs; 2019; 51(1):28-30. PubMed ID: 30620247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute liver injury following short-term use of the herbal supplement kratom.
    Umbehr G; Lukaszewicz M
    JAAPA; 2022 Feb; 35(2):39-41. PubMed ID: 35076438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Kratom Withdrawal and Addiction With Buprenorphine.
    Khazaeli A; Jerry JM; Vazirian M
    J Addict Med; 2018; 12(6):493-495. PubMed ID: 30383616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kratom-Induced Cholestatic Liver Injury and Its Conservative Management.
    Fernandes CT; Iqbal U; Tighe SP; Ahmed A
    J Investig Med High Impact Case Rep; 2019; 7():2324709619836138. PubMed ID: 30920318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic potential of kratom.
    Grundmann O; Brown PN; Henningfield J; Swogger M; Walsh Z
    Addiction; 2018 Oct; 113(10):1951-1953. PubMed ID: 29949213
    [No Abstract]   [Full Text] [Related]  

  • 9. Kratom (Mitragyna speciosa): Friend or Foe?
    Sethi R; Hoang N; Ravishankar DA; McCracken M; Manzardo AM
    Prim Care Companion CNS Disord; 2020 Jan; 22(1):. PubMed ID: 31999896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis of severe obsessions in the setting of kratom withdrawal and treatment with lorazepam: Case report.
    Sablaban IM; Gautam M
    J Addict Dis; 2021; 39(1):138-139. PubMed ID: 32924857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-treatment of opioid withdrawal with a dietary supplement, Kratom.
    Boyer EW; Babu KM; Macalino GE
    Am J Addict; 2007; 16(5):352-6. PubMed ID: 17882605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kratom Use and Toxicities in the United States.
    Eggleston W; Stoppacher R; Suen K; Marraffa JM; Nelson LS
    Pharmacotherapy; 2019 Jul; 39(7):775-777. PubMed ID: 31099038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural drugs, not so natural effects: Neonatal abstinence syndrome secondary to 'kratom'.
    Davidson L; Rawat M; Stojanovski S; Chandrasekharan P
    J Neonatal Perinatal Med; 2019; 12(1):109-112. PubMed ID: 30149482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kratom Withdrawal: A Systematic Review with Case Series.
    Stanciu CN; Gnanasegaram SA; Ahmed S; Penders T
    J Psychoactive Drugs; 2019; 51(1):12-18. PubMed ID: 30614408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evidence-based systematic review of kratom (Mitragyna speciosa) by the Natural Standard Research Collaboration.
    Ulbricht C; Costa D; Dao J; Isaac R; LeBlanc YC; Rhoades J; Windsor RC
    J Diet Suppl; 2013 Jun; 10(2):152-70. PubMed ID: 23725528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management.
    Bowe A; Kerr PL
    J Psychoactive Drugs; 2020; 52(5):447-452. PubMed ID: 32546067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver injury associated with kratom, a popular opioid-like product: Experience from the U.S. drug induced liver injury network and a review of the literature.
    Ahmad J; Odin JA; Hayashi PH; Fontana RJ; Conjeevaram H; Avula B; Khan IA; Barnhart H; Vuppalanchi R; Navarro VJ;
    Drug Alcohol Depend; 2021 Jan; 218():108426. PubMed ID: 33257199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and characteristics of self-reported kratom use in a representative US general population sample.
    Covvey JR; Vogel SM; Peckham AM; Evoy KE
    J Addict Dis; 2020; 38(4):506-513. PubMed ID: 32657217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kratom (Mitragyna speciosa): worldwide issues.
    Ramanathan S; McCurdy CR
    Curr Opin Psychiatry; 2020 Jul; 33(4):312-318. PubMed ID: 32452943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Cognitive Effects of Kratom (Mitragyna speciosa Korth.) Use.
    Singh D; Narayanan S; Müller CP; Vicknasingam B; Yücel M; Ho ETW; Hassan Z; Mansor SM
    J Psychoactive Drugs; 2019; 51(1):19-27. PubMed ID: 30556488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.